Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Zacks Investment Research • 2 days ago • ZTS
Why Zoetis (ZTS) Could Beat Earnings Estimates AgainSeeking Alpha • 2 days ago • ZTS
Zoetis: Poised For Growth Yet Priced For Decline (Rating Upgrade To Strong Buy)Zacks Investment Research • 3 days ago • ZTS
Here's Why Zoetis (ZTS) is a Strong Growth StockZacks Investment Research • 13 days ago • ZTS
SGIOY or ZTS: Which Is the Better Value Stock Right Now?The Motley Fool • 13 days ago • ZTS
3 Magnificent S&P 500 Dividend Stocks Down 19% to 26%: Is It Time to Buy the Dip?Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.